Tentative Approval — This application has been tentatively approved by the FDA but is not yet listed in the Orange Book. It is blocked from final approval by unexpired patents or exclusivities on the reference listed drug.
BEPOTASTINE BESILATE
ANDATentative Approval
BEPOTASTINE BESILATE | A206080 | SANDOZ INC
Products (1)
#001 — 1.5%
▴
SOLUTION;OPHTHALMIC | TA Date: Jun. 7, 2017
No patent or exclusivity listings for this strength.